Pneumonia Testing Market Benefits from Molecular a..

새 기사를 만들었습니다

4 디

Pneumonia Testing Market Benefits from Molecular and Point-of-Care Diagnostics | #healthcare

Pneumonia Testing Market Benefits from Molecular and Point-of-Care Diagnostics

The global market was valued at USD 2.27 billion in 2025 and is projected to grow from USD 2.44 billion in 2026 to USD 4.63 billion by 2035, registering a CAGR of 7.40% during the forecast period

처럼

논평

공유하다